Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Total Current Liabilities (2023 - 2025)

Onconetix (ONCO) has disclosed Total Current Liabilities for 2 consecutive years, with $17.4 million as the latest value for Q3 2024.

  • On a quarterly basis, Total Current Liabilities fell 1.64% to $17.4 million in Q3 2024 year-over-year; TTM through Sep 2024 was $17.4 million, a 1.64% decrease, with the full-year FY2023 number at $17.2 million, changed N/A from a year prior.
  • Total Current Liabilities was $17.4 million for Q3 2024 at Onconetix, down from $20.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $21.4 million in Q1 2024 to a low of $2.8 million in Q1 2023.